Optical coherence tomography in multiple sclerosis

Affiliations

¹ Karl Landsteiner Institute for Neuroimmunological and Neurodegenerative Disorders, Vienna, Austria; Department of Neurology, SMZ-Ost Donauspital, Vienna A-1220, Austria. Electronic address: fahmy.aboulenein@meduniwien.ac.at.
² Department of Ophthalmology, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
³ Karl Landsteiner Institute for Neuroimmunological and Neurodegenerative Disorders, Vienna, Austria.

Comment

Fahmy Aboulenein-Djamshidian et al. Lancet Neurol. 2016 May.

. 2016 May;15(6):537-8.

doi: 10.1016/S1474-4422(16)00113-7. Epub 2016 Mar 24.

¹ Karl Landsteiner Institute for Neuroimmunological and Neurodegenerative Disorders, Vienna, Austria; Department of Neurology, SMZ-Ost Donauspital, Vienna A-1220, Austria. Electronic address: fahmy.aboulenein@meduniwien.ac.at.
² Department of Ophthalmology, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
³ Karl Landsteiner Institute for Neuroimmunological and Neurodegenerative Disorders, Vienna, Austria.

No abstract available

Comment on

Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study.
Martinez-Lapiscina EH, Arnow S, Wilson JA, Saidha S, Preiningerova JL, Oberwahrenbrock T, Brandt AU, Pablo LE, Guerrieri S, Gonzalez I, Outteryck O, Mueller AK, Albrecht P, Chan W, Lukas S, Balk LJ, Fraser C, Frederiksen JL, Resto J, Frohman T, Cordano C, Zubizarreta I, Andorra M, Sanchez-Dalmau B, Saiz A, Bermel R, Klistorner A, Petzold A, Schippling S, Costello F, Aktas O, Vermersch P, Oreja-Guevara C, Comi G, Leocani L, Garcia-Martin E, Paul F, Havrdova E, Frohman E, Balcer LJ, Green AJ, Calabresi PA, Villoslada P; IMSVISUAL consortium. Martinez-Lapiscina EH, et al. Lancet Neurol. 2016 May;15(6):574-84. doi: 10.1016/S1474-4422(16)00068-5. Epub 2016 Mar 18. Lancet Neurol. 2016. PMID: 27011339